Hypergonadotropic hypergonadism

Hypergonadotropic hypergonadism is a medical condition characterized by the increased secretion of gonadotropins (hormones that stimulate the gonads) due to the lack of feedback inhibition by the gonads. This condition is also known as primary gonadal failure or primary hypogonadism, as it results from an intrinsic problem within the gonads themselves, leading to decreased production of sex hormones (estrogen in females and testosterone in males) and, consequently, elevated levels of circulating gonadotropins (FSH and LH).

Causes

Hypergonadotropic hypergonadism can be caused by a variety of factors, including genetic disorders, autoimmune conditions, infections, and physical damage to the gonads. Common genetic disorders associated with this condition include Turner syndrome in females and Klinefelter syndrome in males. Autoimmune conditions, such as autoimmune oophoritis and orchitis, can also lead to the destruction of gonadal tissue. Infections like mumps can affect the gonads, especially the testes, leading to impaired gonadal function. Physical damage, including trauma, surgery, or radiation, can also result in hypergonadotropic hypergonadism.

Symptoms

The symptoms of hypergonadotropic hypergonadism vary depending on the age of onset and the level of sex hormones. In children, the condition can lead to delayed puberty or incomplete development at puberty. Adults may experience symptoms related to the deficiency of sex hormones, such as decreased libido, erectile dysfunction in men, amenorrhea (absence of menstrual periods) in women, and infertility in both sexes. Other symptoms may include hot flashes, fatigue, and decreased bone density, which can lead to osteoporosis.

Diagnosis

Diagnosis of hypergonadotropic hypergonadism involves a combination of clinical evaluation, laboratory testing, and imaging studies. Laboratory tests typically include measurements of serum levels of FSH, LH, estrogen, and testosterone. Elevated levels of FSH and LH, along with decreased levels of sex hormones, are indicative of hypergonadotropic hypergonadism. Imaging studies, such as ultrasound, may be used to assess the structure and function of the gonads.

Treatment

Treatment of hypergonadotropic hypergonadism focuses on the underlying cause, if known, and hormone replacement therapy to manage symptoms related to sex hormone deficiency. Estrogen and progesterone therapy may be prescribed for women, while testosterone replacement therapy is used for men. In cases where fertility is desired, assisted reproductive technologies may be considered. Additionally, patients may require treatment for complications such as osteoporosis.

Prognosis

The prognosis for individuals with hypergonadotropic hypergonadism varies depending on the underlying cause and the effectiveness of treatment. Hormone replacement therapy can effectively manage symptoms related to sex hormone deficiency, but it does not restore fertility in most cases. Early diagnosis and treatment are crucial to prevent complications and improve quality of life.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian